These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30849637)

  • 41. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of
    Wang D; Jia Y; Zheng W; Li C; Cui W
    Dis Markers; 2019; 2019():6019637. PubMed ID: 31885740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Upregulation of the long noncoding RNA FOXD2-AS1 predicts poor prognosis in esophageal squamous cell carcinoma.
    Bao J; Zhou C; Zhang J; Mo J; Ye Q; He J; Diao J
    Cancer Biomark; 2018 Feb; 21(3):527-533. PubMed ID: 29286915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
    Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aberrant methylation-mediated downregulation of long noncoding RNA C5orf66-AS1 promotes the development of gastric cardia adenocarcinoma.
    Guo W; Lv P; Liu S; Xu F; Guo Y; Shen S; Liang J; Kuang G; Dong Z
    Mol Carcinog; 2018 Jul; 57(7):854-865. PubMed ID: 29566283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of miR-1304 in patients with esophageal carcinoma and risk factors for recurrence.
    Luo YG; Duan LW; Ji X; Jia WY; Liu Y; Sun ML; Liu GM
    World J Gastroenterol; 2020 Feb; 26(6):670-685. PubMed ID: 32103875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A group of long noncoding RNAs identified by data mining can predict the prognosis of lung adenocarcinoma.
    Liao M; Liu Q; Li B; Liao W; Xie W; Zhang Y
    Cancer Sci; 2018 Dec; 109(12):4033-4044. PubMed ID: 30290038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NORAD Expression Is Associated with Adverse Prognosis in Esophageal Squamous Cell Carcinoma.
    Wu X; Lim ZF; Li Z; Gu L; Ma W; Zhou Q; Su H; Wang X; Yang X; Zhang Z
    Oncol Res Treat; 2017; 40(6):370-374. PubMed ID: 28482344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Value of long non-coding RNA Rpph1 in esophageal cancer and its effect on cancer cell sensitivity to radiotherapy.
    Li ZY; Li HF; Zhang YY; Zhang XL; Wang B; Liu JT
    World J Gastroenterol; 2020 Apr; 26(15):1775-1791. PubMed ID: 32351293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LncRNA Expression Signature in Prediction of the Prognosis of Lung Adenocarcinoma.
    Li L; Feng T; Qu J; Feng N; Wang Y; Ma RN; Li X; Zheng ZJ; Yu H; Qian B
    Genet Test Mol Biomarkers; 2018 Jan; 22(1):20-28. PubMed ID: 29297704
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
    Zhang L; Yan DL; Yang F; Wang DD; Chen X; Wu JZ; Tang JH; Xia WJ
    Oncotarget; 2017 Jul; 8(28):45496-45505. PubMed ID: 28525377
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
    Huang W; Liu Z; Li Y; Liu L; Mai G
    J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients.
    Diamantopoulos MA; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
    Clin Chem Lab Med; 2017 May; 55(5):737-747. PubMed ID: 27930363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High Expression of miR-206 Predicts Adverse Outcomes: A Potential Therapeutic Target for Esophageal Cancer.
    Du G; Zhou J; Cheng L; Ma X; Gui Y; Tan B
    Comb Chem High Throughput Screen; 2019; 22(9):599-611. PubMed ID: 31648633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma.
    Kawakami K; Brabender J; Lord RV; Groshen S; Greenwald BD; Krasna MJ; Yin J; Fleisher AS; Abraham JM; Beer DG; Sidransky D; Huss HT; Demeester TR; Eads C; Laird PW; Ilson DH; Kelsen DP; Harpole D; Moore MB; Danenberg KD; Danenberg PV; Meltzer SJ
    J Natl Cancer Inst; 2000 Nov; 92(22):1805-11. PubMed ID: 11078757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. USP4 expression independently predicts favorable survival in lung adenocarcinoma.
    Zhong M; Jiang Q; Jin R
    IUBMB Life; 2018 Jul; 70(7):670-677. PubMed ID: 29667299
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The downregulation of lncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer.
    Gu Y; Feng C; Liu T; Zhang B; Yang L
    PLoS One; 2018; 13(12):e0209338. PubMed ID: 30576338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
    Zong MZ; Feng WT; Du N; Yu XJ; Yu WY
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7929-7934. PubMed ID: 31599448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.